ABBV
Price
$180.36
Change
+$1.16 (+0.65%)
Updated
Mar 27, 6:59 PM EST
28 days until earnings call
AMGN
Price
$286.30
Change
+$4.53 (+1.61%)
Updated
Mar 27, 6:59 PM EST
27 days until earnings call
Ad is loading...

Compare trend and price ABBV vs AMGN

Header iconABBV vs AMGN Comparison
Open Charts ABBV vs AMGNBanner chart's image
ABBVIE
Price$180.36
Change+$1.16 (+0.65%)
Volume$1.37M
CapitalizationN/A
Amgen
Price$286.30
Change+$4.53 (+1.61%)
Volume$1.14M
CapitalizationN/A
View a ticker or compare two or three
ABBV vs AMGN Comparison Chart

Loading...

ABBVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
AMGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABBV vs. AMGN commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Hold and AMGN is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ABBV: $180.35 vs. AMGN: $286.31)
Brand notoriety: ABBV and AMGN are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 89% vs. AMGN: 60%
Market capitalization -- ABBV: $319.34B vs. AMGN: $153.44B
ABBV [@Pharmaceuticals: Major] is valued at $319.34B. AMGN’s [@Pharmaceuticals: Major] market capitalization is $153.44B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.87B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 5 FA rating(s) are green whileAMGN’s FA Score has 3 green FA rating(s).

  • ABBV’s FA Score: 5 green, 0 red.
  • AMGN’s FA Score: 3 green, 2 red.
According to our system of comparison, ABBV is a better buy in the long-term than AMGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 5 TA indicator(s) are bullish while AMGN’s TA Score has 4 bullish TA indicator(s).

  • ABBV’s TA Score: 5 bullish, 3 bearish.
  • AMGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than AMGN.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +2.31% price change this week, while AMGN (@Pharmaceuticals: Major) price change was +4.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.81%. For the same industry, the average monthly price growth was -3.02%, and the average quarterly price growth was -1.90%.

Reported Earning Dates

ABBV is expected to report earnings on Apr 25, 2024.

AMGN is expected to report earnings on Apr 24, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.81% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for ABBV with price predictions.
OPEN
A.I.dvisor published
a Summary for AMGN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ABBV($319B) has a higher market cap than AMGN($153B). ABBV has higher P/E ratio than AMGN: ABBV (66.31) vs AMGN (22.92). ABBV YTD gains are higher at: 17.489 vs. AMGN (0.180). ABBV has higher annual earnings (EBITDA): 17.2B vs. AMGN (14.8B). ABBV has more cash in the bank: 12.8B vs. AMGN (10.9B). ABBV has less debt than AMGN: ABBV (59.4B) vs AMGN (64.6B). ABBV has higher revenues than AMGN: ABBV (54.3B) vs AMGN (28.2B).
ABBVAMGNABBV / AMGN
Capitalization319B153B208%
EBITDA17.2B14.8B116%
Gain YTD17.4890.1809,720%
P/E Ratio66.3122.92289%
Revenue54.3B28.2B193%
Total Cash12.8B10.9B117%
Total Debt59.4B64.6B92%
FUNDAMENTALS RATINGS
ABBV vs AMGN: Fundamental Ratings
ABBV
AMGN
OUTLOOK RATING
1..100
144
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
413
SMR RATING
1..100
2812
PRICE GROWTH RATING
1..100
2751
P/E GROWTH RATING
1..100
747
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABBV's Valuation (11) in the Pharmaceuticals Major industry is in the same range as AMGN (17) in the Biotechnology industry. This means that ABBV’s stock grew similarly to AMGN’s over the last 12 months.

ABBV's Profit vs Risk Rating (4) in the Pharmaceuticals Major industry is in the same range as AMGN (13) in the Biotechnology industry. This means that ABBV’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's SMR Rating (12) in the Biotechnology industry is in the same range as ABBV (28) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's Price Growth Rating (27) in the Pharmaceuticals Major industry is in the same range as AMGN (51) in the Biotechnology industry. This means that ABBV’s stock grew similarly to AMGN’s over the last 12 months.

ABBV's P/E Growth Rating (7) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMGN (47) in the Biotechnology industry. This means that ABBV’s stock grew somewhat faster than AMGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVAMGN
RSI
ODDS (%)
Bearish Trend 1 day ago
47%
Bullish Trend 1 day ago
56%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
45%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bearish Trend 7 days ago
57%
Bullish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
48%
Advances
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
57%
Declines
ODDS (%)
Bearish Trend 21 days ago
47%
Bearish Trend 14 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
50%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
46%
View a ticker or compare two or three
Ad is loading...
ABBVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
AMGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEBO29.131.05
+3.74%
Peoples Bancorp
FSI1.900.06
+3.26%
Flexible Solutions International
RCL139.722.85
+2.08%
Royal Caribbean Group
WIRE253.194.14
+1.66%
Encore Wire Corp
RLGT5.310.04
+0.76%
Radiant Logistics

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+0.65%
PFE - ABBV
54%
Loosely correlated
+0.69%
JNJ - ABBV
37%
Loosely correlated
+1.41%
MRK - ABBV
33%
Loosely correlated
+4.96%
AMGN - ABBV
32%
Poorly correlated
+1.61%
AZN - ABBV
28%
Poorly correlated
+2.89%
More

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with GILD. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then GILD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+1.61%
GILD - AMGN
44%
Loosely correlated
+0.83%
JNJ - AMGN
36%
Loosely correlated
+1.41%
BIIB - AMGN
33%
Loosely correlated
+2.03%
BMY - AMGN
33%
Poorly correlated
+1.33%
ABBV - AMGN
32%
Poorly correlated
+0.65%
More